We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hydrogen-rich water alleviates inflammation and fatigue in COVID-19: A pilot study.
- Authors
Milovancev, Aleksandra; Avakumovic, Jovana; Drid, Patrik; Todorovic, Nikola; Stajer, Valdemar; Ostojic, Sergej M
- Abstract
Serum interleukin six dropped for 5.8% after HRW intervention and increased for 16.2% in the control group ( I p i = 0.04) (Figure 1); the levels were reduced in all female patients after HRW intervention (10 out of 10 patients), and in 60.0% of women (3 out of 5 patients) in the control group ( I p i = 0.02). Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial. Dear Editor, Molecular hydrogen (H SB 2 sb ) has been recently put forward as a possible adjunct therapeutics in COVID-19 due to its anti-inflammatory and pulmo-protective effects.[1],[2] An open-label randomized trial in 44 patients with laboratory-confirmed COVID-19 from seven hospitals in China demonstrated that 3-day hydrogen inhalation resulted in significantly more patients with improved disease severity and reduced dyspnea comparing to patients who received standard-of-care treatment.[3] The authors suggested that the clinical benefits were likely due to the ability of hydrogen to decrease the inspiratory efforts that consequently reduces chest distress and pain in COVID-19 patients.
- Subjects
COUGH; PILOT projects; COVID-19; CHEST pain
- Publication
European Journal of Inflammation, 2022, p1
- ISSN
1721-727X
- Publication type
Letter
- DOI
10.1177/1721727X221094197